Moreover, Treg cells in the melanoma tumor microenvironment are driven by CD8+ T cells,54 which indicates that patients with elevated Treg cells could have augmented CD8+ T cells simultaneously, thus having an improved survival. This evidence concerns the gene CD8A and neoplasm.